Oriol Yuguero1,2, Jose Manuel Fernández-Armenteros3, Álvaro Vilela1,4, Jesús Aramburu2,5, Raquel Laín1, Pere Godoy1,2,6,7. 1. Institut de Recerca Biomédica de Lleida Fundació Dr. Pifarré (IRBLleida), Lleida, Spain. 2. Facultat de Medicina, Universitat de Lleida, Lleida, Spain. 3. Secció de Dermatologia, Hospital Universitari, Lleida, Spain. 4. Cap Onze de Setembre, Institut Català de la Salut, Lleida, Spain. 5. Secció Microbiologia, Laboratori Clínic, Hospital Universitari Arnau de VIlanova (HUAV), Lleida, Spain. 6. Agència de Salut Pública de Catalunya, Lleida, Spain. 7. Centro Investigación Biomédica en Red (CIBER) de Epidemiología y Salud Pública, Epidemiology and Public Health Networking Biomedical Research Centre (CIBERESP), Madrid, Spain.
Abstract
Introduction: Chlamydia trachomatis (CT) infection has increased in recent years, reaching 127 million cases in 2016. Possible complications, especially among women, require intervention for early detection of the infection. The objective of our study was to determine the prevalence of CT infection in a young, sexually active, asymptomatic population. Methods: A cross-sectional study was conducted between December 2017 and 31 December 2018 among young patients aged 18-25 years attending the emergency room for any reason. The presence of CT and other STIs in urine was determined by the Allplex Nucleic Acid Amplification Test (NAAT) with a urine sample. All patients testing positive were followed by the STD unit and tests on all sexual partners/contacts were offered. Moreover, we obtained data about sexual habits and risk factors via a self-reporting questionnaire. Results: One thousand three hundred eight patients were eligible for inclusion of whom 298 consented to participate. Of these, 22/298 (7.4%) were diagnosed with CT. Young people with two or more sexual partners in the last month and those suffering from infection by ureaplasma were at greater risk of infection by CT. Up to 50% of participants do not use barrier methods. Conclusion: The prevalence of infection by CT in the asymptomatic young population is higher than expected according to the recent literature in Spain. The scarce use of barrier methods among this population may be one of the causes of this increase and one of the targets to work on in order to reduce the prevalence of the infection.
Introduction: Chlamydia trachomatis (CT) infection has increased in recent years, reaching 127 million cases in 2016. Possible complications, especially among women, require intervention for early detection of the infection. The objective of our study was to determine the prevalence of CTinfection in a young, sexually active, asymptomatic population. Methods: A cross-sectional study was conducted between December 2017 and 31 December 2018 among young patients aged 18-25 years attending the emergency room for any reason. The presence of CT and other STIs in urine was determined by the Allplex Nucleic Acid Amplification Test (NAAT) with a urine sample. All patients testing positive were followed by the STD unit and tests on all sexual partners/contacts were offered. Moreover, we obtained data about sexual habits and risk factors via a self-reporting questionnaire. Results: One thousand three hundred eight patients were eligible for inclusion of whom 298 consented to participate. Of these, 22/298 (7.4%) were diagnosed with CT. Young people with two or more sexual partners in the last month and those suffering from infection by ureaplasma were at greater risk of infection by CT. Up to 50% of participants do not use barrier methods. Conclusion: The prevalence of infection by CT in the asymptomatic young population is higher than expected according to the recent literature in Spain. The scarce use of barrier methods among this population may be one of the causes of this increase and one of the targets to work on in order to reduce the prevalence of the infection.
Authors: G P Joffe; B Foxman; A J Schmidt; K B Farris; R J Carter; S Neumann; K A Tolo; A M Walters Journal: Sex Transm Dis Date: 1992 Sep-Oct Impact factor: 2.830
Authors: Charlotte A Gaydos; Michele-Corinne Ako; Mitra Lewis; Yu-Hsiang Hsieh; Richard E Rothman; Andrea F Dugas Journal: Ann Emerg Med Date: 2018-11-02 Impact factor: 5.721
Authors: Magnus Unemo; Catriona S Bradshaw; Jane S Hocking; Henry J C de Vries; Suzanna C Francis; David Mabey; Jeanne M Marrazzo; Gerard J B Sonder; Jane R Schwebke; Elske Hoornenborg; Rosanna W Peeling; Susan S Philip; Nicola Low; Christopher K Fairley Journal: Lancet Infect Dis Date: 2017-07-09 Impact factor: 25.071
Authors: Jeanne Cabeza; Patricia J García; Eddy Segura; Pedro García; Francisco Escudero; Sayda La Rosa; Segundo León; Jeffrey D Klausner Journal: Sex Transm Infect Date: 2014-08-08 Impact factor: 3.519
Authors: Shelagh M Redmond; Karin Alexander-Kisslig; Sarah C Woodhall; Ingrid V F van den Broek; Jan van Bergen; Helen Ward; Anneli Uusküla; Björn Herrmann; Berit Andersen; Hannelore M Götz; Otilia Sfetcu; Nicola Low Journal: PLoS One Date: 2015-01-23 Impact factor: 3.240
Authors: Lori Newman; Jane Rowley; Stephen Vander Hoorn; Nalinka Saman Wijesooriya; Magnus Unemo; Nicola Low; Gretchen Stevens; Sami Gottlieb; James Kiarie; Marleen Temmerman Journal: PLoS One Date: 2015-12-08 Impact factor: 3.240
Authors: E M Harding-Esch; E C Cousins; S-L C Chow; L T Phillips; C L Hall; N Cooper; S S Fuller; A V Nori; R Patel; S Thomas-William; G Whitlock; S J E Edwards; M Green; J Clarkson; B Arlett; J K Dunbar; C M Lowndes; S T Sadiq Journal: EBioMedicine Date: 2018-01-10 Impact factor: 8.143
Authors: Pam Sonnenberg; Soazig Clifton; Simon Beddows; Nigel Field; Kate Soldan; Clare Tanton; Catherine H Mercer; Filomeno Coelho da Silva; Sarah Alexander; Andrew J Copas; Andrew Phelps; Bob Erens; Philip Prah; Wendy Macdowall; Kaye Wellings; Catherine A Ison; Anne M Johnson Journal: Lancet Date: 2013-11-26 Impact factor: 79.321
Authors: A Muñoz Santa; A Bellés Bellés; E López González; I Prats Sánchez; S Mormeneo Bayo; A Bernet Sánchez; J Aramburu Arnuelos; M Font Font; L Fraile García; M Garcia González Journal: Rev Esp Quimioter Date: 2021-12-10 Impact factor: 1.553